Back to Journals » International Journal of High Throughput Screening » Volume 3

The development of a high-throughput/ combinatorial workflow for the study of porous polymer networks

Authors

Majumdar P, Bahr J, Crowley E, Kallam A, Gubbins N, Schiele K, Weisz M, Dirk SM, Lenhart JL, Chisholm BJ

Received 15 October 2011

Accepted for publication 15 December 2011

Published 11 April 2012 Volume 2012:3 Pages 1—12

DOI https://doi.org/10.2147/IJHTS.S27359

Review by Single-blind

Peer reviewer comments 3

Partha Majumdar1, James Bahr1, Elizabeth Crowley1, Alekhya Kallam1, Nathan Gubbins1, Kris Schiele1, Michael Weisz1, Shawn M Dirk3, Joseph L Lenhart4, Bret J Chisholm1,2
1Center for Nanoscale Science and Engineering, 2Department of Coatings and Polymeric Materials, North Dakota State University, Fargo, North Dakota, 3Sandia National Laboratories, Albuquerque, New Mexico, 4US Army Research Laboratory, Aberdeen, Maryland, USA

Abstract: A high-throughput workflow was developed for the study of porous polymers generated using the process of chemically induced phase separation. The workflow includes automated, parallel preparation of liquid blends containing reactive, polymer network-forming precursors and a poragen, as well as a high-throughput poragen extraction process using supercritical CO2. A structure–process–property relationship study was conducted using epoxy-amine cross-linked networks. The experimental design involved variations in polymer network cross-link density, poragen composition, poragen level, and cure temperature. A total of 216 unique compositions were prepared. Changes in opacity of the blends as they cured were monitored visually. Morphology was characterized using a scanning electron microscope on a subset of the 216 samples. The results obtained allowed for the identification of compositional variables and process variables that enabled the production of porous networks.

Keywords: high-throughput, chemically induced phase separation, porous polymer, poragen

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M

Patient Preference and Adherence 2014, 8:1713-1720

Published Date: 12 December 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010